Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 6/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | AOC2 | O75106 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | PDE2A | O00408 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6618975 | 0.92 | CYP19A1 (0.48) | CYP11B2CYP11B1AOC3CYP3A4CYP2D6 | |
| SCHEMBL6619017 | 0.91 | CYP19A1 (0.47) | CYP11B2CYP11B1AOC3CYP3A4CYP2D6 | |
| SCHEMBL1378188 | 0.87 | CYP11B2 (0.46) | CYP11B2CYP11B1AOC3AOC2G6PD | |
| SCHEMBL2214832 | 0.87 | CYP11B2 (0.46) | CYP11B2CYP11B1AOC3G6PDPDE2A | |
| SCHEMBL2213278 | 0.86 | CYP11B2 (0.45) | CYP11B2CYP11B1AOC3AOC2G6PD | |
| SCHEMBL2215534 | 0.86 | CYP11B2 (0.46) | CYP11B2CYP11B1AOC3G6PDHRH3 | |
| SCHEMBL2215667 | 0.85 | CYP11B2 (0.60) | CYP11B2CYP11B1AOC3CYP19A1AOC2 | |
| SCHEMBL2212913 | 0.80 | ALDH1A1 (0.44) | CYP11B2CYP11B1AOC3G6PDHRH3 | |
| SCHEMBL2211748 | 0.80 | PPARG (0.47) | CYP11B2CYP11B1AOC3G6PDHRH3 | |
| SCHEMBL7717836 | 0.80 | PDE10A (0.51) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1474415-A1 | 1-PHENYL-2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, THE USE THEREOF FOR PRODUCING DRUGS USED IN THE TREATMENT OF IMMUNOLOGICAL DISEASES | Schering Aktiengesellschaft (DE) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003068766-A1 | 1-PHENYL-2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, THE USE THEREOF FOR PRODUCING DRUGS USED IN THE TREATMENT OF IMMUNOLOGICAL DISEASES | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-08-21 | — | — | WO | disclosed |